...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: you won’t see anyone buying this

"I don't see pockets being lined just the superb management skills that Toinvest and others have been pointing out for a number of years"

Over 30% dilution in 2 years looks like superb management skills at lining pockets to me. Not sure who's pockets but there stuffed to the point they can't get their hands in them.

Share
New Message
Please login to post a reply